Roberts René L, Small Ralph E
Virginia Commonwealth University, School of Pharmacy, 410 North 12th Street, PO Box 980533, Richmond, VA 23298-0533, USA.
Curr Hypertens Rep. 2002 Dec;4(6):420-3. doi: 10.1007/s11906-002-0020-7.
Hypertension is a common disease among the elderly, a population that will continue to grow over the next decade. Untreated hypertension can lead to cardiovascular events and mortality. Given the seriousness of this disease and the increase in the number of elderly with hypertension, this review focuses on the cost of treating hypertension in the elderly as described in recent publications. We found a limited number of articles related to the treatment of hypertension in the elderly. One publication provided insightful information pertaining to expenditures in the United States for hypertension in 1998. This article was the first to examine age distribution among persons 65 years and older. It has been shown that antihypertensive pharmacologic treatment significantly reduces the incidence of cardiovascular events. Without any other medical conditions, thiazide-like diuretics are recommended for the treatment of hypertension in the elderly due to their beneficial effects, low risk for side effects, and low cost. In general, it was found that the elderly have higher expenditures per capita for hypertension and per hypertensive condition.
高血压是老年人中的常见疾病，在未来十年这一人群数量将持续增长。未经治疗的高血压会导致心血管事件和死亡。鉴于这种疾病的严重性以及老年高血压患者数量的增加，本综述聚焦于近期出版物中所描述的老年高血压治疗成本。我们发现与老年高血压治疗相关的文章数量有限。一篇出版物提供了关于1998年美国高血压支出的有见地信息。这篇文章首次研究了65岁及以上人群的年龄分布。研究表明，抗高血压药物治疗可显著降低心血管事件的发生率。在没有任何其他疾病的情况下，由于噻嗪类利尿剂有益、副作用风险低且成本低，因此推荐用于老年高血压的治疗。总体而言，研究发现老年人高血压人均支出和每种高血压疾病的支出更高。
